Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336
Alvaro Moreno-Aspitia, Roscoe F. Morton, David W. Hillman, Wiltna L. Lingle, Kendrith M. Rowland, Martin Wiesenfeld, Patrick J. Flynn, Tom R. Fitch, Edith A. Perez
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336'. Together they form a unique fingerprint.